| Andrea Douglas, MS | |
|
2711 W 15th St, Panama City, FL 32401-1366 | |
| (850) 769-6001 | |
| Not Available |
| Full Name | Andrea Douglas |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2711 W 15th St, Panama City, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033510375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Douglas, MS 201 Crescent Dr, Dothan, AL 36303-2910 Ph: (334) 791-2576 | Andrea Douglas, MS 2711 W 15th St, Panama City, FL 32401-1366 Ph: (850) 769-6001 |
News Archive
For many shoppers the word "organic" is synonymous with "safe." But food safety experts cannot concede that organic is safer than conventional food, as their research shows it is not. Dialogue on the confusion between fact and myth highlighted the Institute of Food Technologists Annual Meeting and Food Expo.
MedImmune announced today it will present 11 abstracts at the Pediatric Academic Societies Meeting at the Colorado Convention Center in Denver, CO, April 30 - May 3, 2011.
On one day, Tuesday, September 22nd, Positively Aware and TPAN are inviting everyone, regardless of HIV status, to get in the picture and participate in A Day with HIV, the magazine's sixth annual anti-stigma photo campaign. On 9/22/2015 people across the world, whether HIV-positive or negative, will visually capture and share a moment of their day – A Day with HIV – to focus attention on what it means to live in a world with HIV.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
BioDelivery Sciences International, Inc. today announced a positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) which took place on September 14, 2010. At that meeting, agreement was reached on the BEMA Buprenorphine development plan for the treatment of chronic pain.
› Verified 1 days ago
Angela Gruber, Counselor Medicare: Not Enrolled in Medicare Practice Location: 525 E 15th St, Panama City, FL 32405 Phone: 850-522-4485 Fax: 850-522-4484 | |
Cheryl Powell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 525 E 15th St, Panama City, FL 32405 Phone: 850-522-4485 Fax: 850-522-4484 | |
Anita Losoya-evon, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 2711 W 15th St, Panama City, FL 32401 Phone: 850-769-6001 | |
Sakeena Powe, M.S Counselor Medicare: Not Enrolled in Medicare Practice Location: 2711 W 15th St, Panama City, FL 32401 Phone: 850-769-6001 | |
Samantha Ashley Morrison, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 2711 W 15th St, Panama City, FL 32401 Phone: 850-769-6001 | |
Ms. Jeanie J. Wolter, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 648 Florida Ave, Panama City, FL 32401 Phone: 850-769-6001 Fax: 850-769-6003 | |
Kelly Bennett, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2711 W 15th St, Panama City, FL 32401 Phone: 850-769-6001 |